CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 216 enrolled
Drug / intervention
doripenemdrug
Likely dose
doripenem 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00986102
NCT00986102Phase 4Completed
CompareCT.gov

A Prospective Study on the Usage Patterns of Doripenem in the Asia Pacific Region

Janssen Research & Development, LLC·interventional·Posted Sep 29, 2009·Updated Nov 19, 2024

In Brief

A Phase 4 clinical trial evaluating doripenem for Pneumonia and 2 related conditions. Completed, enrolled 216 participants across 16 sites in 5 countries.

Detailed Summary

The purpose of this study is to understand the utilization patterns of doripenem in Asia Pacific, including the profile of the patients treated with carbapenems.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPneumonia, Pneumonia, Ventilator-Associated, Urinary Tract Infections
CountriesHong Kong, Indonesia, Malaysia, Singapore, Vietnam
CollaboratorsJohnson & Johnson (Hong Kong) Ltd.

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 29, 2009
Enrollment StartJul 17, 2009
Primary CompletionSep 5, 2011
Study CompletionSep 9, 2011
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 16.8 years ago

Interventions

doripenemdrug

500mg vial by injection every 8 hours for 5 to 14 days